Focus of research group (I)

Slides:



Advertisements
Similar presentations
The Expression of NPPA Splice Variants During Cardiac Differentiation of Mouse Mesenchymal and Embryonic Stem Cells Masoumeh Fakhr Taha PhD, Arash Javeri.
Advertisements

Cardiovascular Disaster in Hemodialysis patients
Developmental Anomalies Consortium Nick Greene UCL Institute of Child Health MRC Mouse Network Meeting – Jan 2012.
April 1 st, 2013 Heart Failure Education Series David N. Edwards, M.D. Ph.D. F.A.C.C. Advanced Heart Care, PA The Heart Hospital Baylor Plano.
Evdokia Anagnostou, MD Clinician Scientist, Holland Bloorview Kids Rehab Hospital Associate Professor, Department of Pediatrics University of Toronto Canada.
Objectives of the Center Facilitate multidisciplinary research, training and information transfer –Kidney physiology –Kidney cell biology –Kidney pathophysiology.
Session III – Models of TdP Proarrhythmia Co-Chairs: Wilhelm Haverkamp and Marc Vos Rapporteurs: Chris Lawrence, Hal Feldman and Alexander Breidenbach.
Transformation of Lifelong Learning Division. Lifelong Learning Division Mission ACCF will become the industry benchmark and source of choice for Lifelong.
Biological pathway and systems analysis An introduction.
1 Batten animal research Network :Lincoln NZ Finnish and Variant Late Infantile Batten Disease David Palmer, Lucy Barry, Hannah Lee, Nadia Mitchell, Janet.
KCNQ1 and Long QT Syndrome
Computational research for medical discovery at Boston College Biology Gabor T. Marth Boston College Department of Biology
MRC Mouse Network Jan 2012 Mouse eyes and vision research consortium Prof Marcela Votruba PhD FRCOphth Prof Ian Jackson PhD.
FINDING THE DISEASE GENES PROGRESS AND PROBLEMS THE HUMAN GENOME MAPPING PROJECT SEEKS TO READ THE FULL SEQUENCE OF THE HUMAN GENOME 3 Billion bases.
Cardiovascular Trait (CVT) Consortium Patricia Munroe.
MRC Respiratory Development and Disease Consortium Dr Matt Hind and Dr Charlotte Dean National Heart and Lung Institute, Imperial College and MRC Harwell.
William M. Miles, MD, FHRS University of Florida College of Medicine Gainesville, FL ICD Implantation: Genetic Arrhythmia Syndromes.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
NCB Noël Barengo, MD, PhD, MPH Department of Public Health University of Helsinki, Finland Unit of Clinical Research, University Hospital La Paz,
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Approach to Palpitations
Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.
CoRPS Center of Research on Psychology in Somatic diseases Poor health status in implantable cardioverter defibrillator patients: Shock, patient pre implantation.
Ethical Scenario: Cardiovascular System
Bonnie Ky, MD, MSCE Assistant Professor of Medicine and Epidemiology
Research projects for PhD/ Masters degree
Statistical modelling of complex biological mechanisms by combining multiple data sources: an example on gene environment interactions Prof. Jeanine. J.
Jonathan Bomar1, Scott Collins Ph.D1,2, and Rosemary Smith Ph.D1,3
Genetics of Brugada syndrome
KnowEnG: A SCALABLE KNOWLEDGE ENGINE FOR LARGE SCALE GENOMIC DATA
Next-generation sequencing increases the diagnostic yield in aborted sudden cardiac death caused by hereditary heart disease   Brøndberg AK1, Christiansen.
Susan Shur-Fen Gau, M.D., PH.D.
NF1 Low-Grade Glioma Synodos
Brugada’s Syndrome and Sudden Cardiac Death
Honours Research Projects on Cataract
Adam T. Wright1, Alice E. Zemljic-Harpf2,3, Jeffrey H
Precision Cardiovascular Medicine: State of Genetic Testing
Cardiac ion channels in health and disease
Cell Phenotyping Facility
Volume 15, Issue 1, Pages (January 2018)
Human Induced Pluripotent Stem Cells: Now Open to Discovery
Cardiovascular Diseases Faculty of Medicine Second Annual Retreat
Stress Pathways and Heart Failure
Lecture 7: Biological Network Crosstalk Y. Z
Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development  Richard P. Davis, Cathelijne W. van den Berg,
Focus of research group (I)
Focus of research group (I)
Focus of research group (I)
Focus of research group – AFib
Focus of research group (I)
Focus of research group (I)
Focus of research group (I)
Robert Zweigerdt, Ina Gruh, Ulrich Martin  Cell Stem Cell 
Human Induced Pluripotent Stem Cells: Now Open to Discovery
Precision Cardiovascular Medicine: State of Genetic Testing
Alexandra M. Dainis, and Euan A. Ashley BTS 2018;3:
Volume 11, Issue 1, Pages (January 2014)
Florian T. Merkle, Kevin Eggan  Cell Stem Cell 
Detecting Cellular Atrial Remodeling Using Confocal Microscopy
International Journal of Cardiology
Focus of research group (I)
Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development  Richard P. Davis, Cathelijne W. van den Berg,
Andrew D. Krahn, MD, Shubhayan Sanatani, MD, Martin J
Gerald V Naccarelli, MD, Charles Antzelevitch, PhD 
Diagnosis at presentation and diagnoses finally reached at the end of the inpatient admission. Diagnosis at presentation and diagnoses finally reached.
The FaceBase Consortium
LiSyM- Pillar II Chronic liver disease progression
Focus of research group - HCM
CRISPR Craze to Transform Cardiac Biology
Presentation transcript:

Focus of research group (I) Name PI: Carol Ann Remme MD PhD Department, UMC: Experimental Cardiology, AMC Size of research group: 2 postdocs, 4 PhD students, 1 technician Current mission, vision and aims To identify novel disease mechanisms underlying (inherited) arrhythmias and sudden cardiac death To understand (variable) disease expressivity in inherited arrhythmia syndromes using mouse and human disease models Brugada syndrome, Long QT syndrome Arrhythmogenic cardiomyopathy (ACM) To develop novel therapeutic strategies for preventing (inherited) arrhythmias and sudden cardiac death

Focus of research group (II) Current expertise: Basic and translational electrophysiology In vivo/whole heart electrophysiology (ECG, optical/electrical mapping, arrhythmia inducibility) Cellular electrophysiology (patch clamp, calcium fluorescence) Histology, immunofluorescence, molecular analyses Disease models: transgenic mice, human iPSC-derived cardiomyocytes, human atrial cardiomyocytes (AF) Current funding NWO-VIDI (Carol Ann Remme) CVON-eDETECT (Carol Ann Remme, WP leader) CVON-PREDICT2 (Carol Ann Remme, WP leader, start 1-1-2019) FONDATION LEDUCQ (Connie Bezzina, Carol Ann Remme) ACS Out of the Box (Carol Ann Remme, Diederik Kuster) AMC Foundation (Carol Ann Remme, start 1-1-2019) ZonMw Off Road (Vincent Portero, start 1-1-2019)

Future plans Short term (1-2 year) plan Plan: Functional studies of newly identified genes and disease mechanisms (e.g. microtubule network, metabolic pathways) Necessary infrastructure: Larger scale hiPSC facilities Imaging techniques Medium-throughput electrophysiology (Multi Electrode Array) Long term (>2 year) plan Establish (non-)genetic modifiers of arrhythmia risk Identify and test new arrhythmia mechanisms and therapies Necessary infrastructure (in addition): Larger scale mouse electrophysiological phenotyping facilities High-throughput electrophysiology (automated patch clamp) Collaboration in ACS Connie Bezzina, Arthur Wilde, Joris de Groot, Arie Verkerk, Vivian de Waard, Diederik Kuster